The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers

E.A.M. Heijnsdijk; J. Adolfsson; A. Auvinen; M.J. Roobol; J. Hugosson; H.J de Koning

doi:10.1016/j.eururo.2019.04.007

The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers

E.A.M. Heijnsdijk, J. Adolfsson, A. Auvinen, M.J. Roobol, J. Hugosson, H.J de Koning

Research output: Contribution to journal › Article › Scientific › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	276-279
Journal	European Urology
Volume	76
Issue number	3
DOIs	https://doi.org/10.1016/j.eururo.2019.04.007
Publication status	Published - 2019
Publication type	A1 Journal article-refereed

Keywords

PSA screening
Prostate cancer
Prostate cancer mortality
Trial

Publication forum classification

Publication forum level 3

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2019.04.007

Cite this

@article{bc0e2094c4f845f0afc5c671d860176e,

title = "The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers",

keywords = "PSA screening, Prostate cancer, Prostate cancer mortality, Trial, PSA screening, Prostate cancer, Prostate cancer mortality, Trial",

author = "E.A.M. Heijnsdijk and J. Adolfsson and A. Auvinen and M.J. Roobol and J. Hugosson and {de Koning}, H.J",

year = "2019",

doi = "10.1016/j.eururo.2019.04.007",

language = "English",

volume = "76",

pages = "276--279",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers

AU - Heijnsdijk, E.A.M.

AU - Adolfsson, J.

AU - Auvinen, A.

AU - Roobol, M.J.

AU - Hugosson, J.

AU - de Koning, H.J

PY - 2019

Y1 - 2019

KW - PSA screening

KW - Prostate cancer

KW - Prostate cancer mortality

KW - Trial

KW - PSA screening

KW - Prostate cancer

KW - Prostate cancer mortality

KW - Trial

U2 - 10.1016/j.eururo.2019.04.007

DO - 10.1016/j.eururo.2019.04.007

M3 - Article

SN - 0302-2838

VL - 76

SP - 276

EP - 279

JO - European Urology

JF - European Urology

IS - 3

ER -